Professor Palsson co-founded a biotechnology company, Aastrom Biosciences (NASDAQ: ASTM) in 1988 where he served as the Vice President of Developmental Research for two years. He is also the founder or co-founder of Oncosis, a company that is focused on the purging of occult tumor cells in autologous bone marrow transplants, Genomatica, a company that is focused on in silico biology, and the Iceland Genomics Corporation, a company that is focused on tracing the genetic basis for common human diseases in the Icelandic population.
BERNHARD O. PALSSON
Bernhard O. Palsson is a Professor of Bioengineering and Adjunct Professor of Medicine at the University of California, San Diego. Professor Palsson is the author of over 140 peer reviewed scientific articles and 18 U.S. patents, many of which are in the area of hematopoietic stem cell transplantation, cell culture technology, bioreactor design, gene transfer, and metabolic engineering. He received his Ph.D. from the University of Wisconsin-Madison Department of Chemical Engineering in 1984. He sits on the editorial boards of several leading peer-reviewed bioengineering and biotechnology journals. Professor Palsson held a faculty position and the University of Michigan for 11 years from 1984 to 1995. He received an Institute of International Education Fellowship in 1977, a Rotary Fellowship in 1979, and a NATO fellowship in 1984. He was named the G.G. Brown Associate Professor at Michigan in 1989, a Fulbright Fellow in 1995, and an Ib Henriksen Fellow in 1996. His current research at UCSD focuses on the construction of genome-scale models of cellular metabolism, and on stem cell fate processes.